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Abstract The aim of logistic regression is to estimate
genetic effects on disease risk, while survival analysis aims
to determine effects on age of onset. In practice, genetic
variants may affect both types of outcomes. A cure survival
model analyzes logistic and survival effects simultane-
ously. The aim of this simulation study is to assess the
performance of logistic regression and traditional survival
analysis under a cure model and to investigate the benefits
of cure survival analysis. We simulated data under a cure
model and varied the percentage of subjects at risk for
disease (cure fraction), the logistic and survival effect
sizes, and the contribution of genetic background risk
factors. We then computed the error rates and estimation
bias of logistic, Cox proportional hazards (PH), and cure
PH analysis, respectively. The power of logistic and Cox
PH analysis is sensitive to the cure fraction and background
heritability. Our results show that traditional Cox PH
analysis may erroneously detect age of onset effects if no
such effects are present in the data. In the presence of
genetic background risk even the cure model results in
biased estimates of both the odds ratio and the hazard ratio.
Cure survival analysis takes cure fractions into account and
can be used to simultaneously estimate the effect of genetic
variants on disease risk and age of onset. Since genome-
wide cure survival analysis is not computationally feasible,
we recommend this analysis for genetic variants that are
significant in a traditional survival analysis.
Keywords Proportional hazards model  Logistic
regression  Cox regression  Accelerated failure time
model  Simulation study
Introduction
In the last decade many genome-wide association (GWA)
studies have been published. The GWAS catalog currently
contains 1924 GWA studies (www.genome.gov/gwas
tudies, accessed June 27, 2014) (Welter et al. 2014). For
example, in the field of psychiatry, the Psychiatric Geno-
mics Consortium (PGC) has reported GWA analyses on
diseases such as ADHD (Neale et al. 2010), bipolar dis-
order (Sklar et al. 2011), major depressive disorder (Ripke
et al. 2012), and schizophrenia (Schizophrenia Working
Group of the Psychiatric Genomics Consortium 2014).
These studies typically include thousands or tens of thou-
sands of subjects with the aim of identifying genetic vari-
ants that affect the risk of developing a disorder.
Alternatively, researchers have aimed to identify genetic
variants that affect age of onset of a disease. For example,
Bergen et al. (2014) investigated which genetic variants
affect age of onset in 2762 schizophrenia patients but did
not find genome-wide significant SNPs, possibly due to
lack of power. Identifying genetic variants which con-
tribute to disease risk and age of onset are both legitimate
research goals for which different analysis methods are
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typically applied. Risk of disorder is typically analyzed
using logistic regression, while time to onset is often
analyzed using survival analysis. In previous studies, the
focus has been on the analysis of either disease risk or age
of onset as separate outcome measures, while in reality a
genetic variant may influence both types of outcome. In
this study, we will evaluate the possibility of incorporating
genetic effects on disease risk and age of onset within a
single analysis using data simulation. We aim to investi-
gate the implications of performing a traditional analysis in
which genetic variants are assumed to show only a single
type of genetic effect, while both types of effects are in fact
present. Results will be compared with those of a more
complex type of survival analysis, allowing for simulta-
neous estimation of disease risk and age of onset effects.
As the name implies, survival analysis can be applied to
analyze survival times or, equivalently, age of death.
However, the event of interest need not be death, but can be
of any type, including timing of disease onset and disease
relapse. In genetic survival analysis we may be interested
in estimating genetic effects on time of disease onset. This
type of analysis addresses the question whether risk allele
carriers develop a disease at an earlier age than non-
carriers.
For many diseases, the majority of subjects in a sample
will not develop the disease during their lifetime. The fact
that some subjects may never be affected by the disease of
interest poses a problem for survival analysis. Traditional
survival analysis treats all unaffected subjects similarly.
However, there may be a qualitative difference between
subjects that have not yet experienced the event and those
that never will. Cure models can accommodate this by
modelling disease risk (i.e., lifetime affected vs. lifetime
unaffected) with a logistic model and only for lifetime
affected cases the time to event is modeled with a survival
model (Othus et al. 2012). The name ‘cure’ refers to the
original development of the model in the context of long-
term survival of cancer patients after treatment. In that
context cure models explicitly model a subset of cured
cancer patients, called the cure fraction, that die at ages more
similar to healthy people compared to patients who are not
cured (Prasad 2014). However, cure models can be applied to
any context in which a subset of subjects is not affected by
the event of interest. In this article, a cure model assumes
populations are a mixture of subjects who will never develop
the disorder of interest and those who will. In this case the
proportion of subjects who will never develop the disorder
would be the ‘cure’ fraction as for this group survival effects
and time to disease onset are not applicable.
In this simulation study we apply the cure model to
introduce both logistic and survival effects for a genetic
variant. We investigate the bias in parameter estimation
when performing a traditional survival analysis while
including two types of genetic effects in the simulation
model. Additionally, we investigate the implications of
ignoring genetic background risk on the estimates. Heri-
table phenotypes often show a complex genetic architec-
ture, meaning that many genetic variants contribute to the
phenotype (Gratten et al. 2014). Since genetic variants are
typically analyzed one at a time, the genetic background
risk from other genetic variants is ignored. This can result
in biased effect estimates (Gail et al. 1984; Stringer et al.
2011). Therefore we will simulate cure model data with
and without the presence of genetic background risk.
In this study we aim to address the following two
research questions. The first question regards the influence
of a cure fraction on parameter estimation in traditional
logistic analysis and survival analysis. The second question
concerns the feasibility of analyzing data using the exten-
ded cure survival model. We will investigate whether the
cure model offers advantages over traditional survival
analysis. To answer these questions we look at several
characteristics of the analysis models: test characteristics
such as type-1 error rate and power, bias in the effect size
estimates, sensitivity to ignored genetic background risk,




Data were simulated according to a cure model with a
logistic component and a survival component. The logistic
component models the probability of being affected by
disease. It divides the population in two distinct subpopu-
lations: subjects at risk and subjects not at risk. The pro-
portion of subjects not at risk is the cure fraction. Cure
fractions range from 0 to 1, with 1 representing a situation
in which no subject will be affected during their lifetime
and 0 representing a situation in which all subjects will
become affected eventually. While a cure fraction of 1 is
not very useful to consider, because there would be no
variation in the data, a cure fraction of 0 is effectively a
traditional survival model, since all subjects will in prin-
ciple develop the disease during their lifetime. In that case
the logistic part of the model is not defined. The cure
fraction is mostly determined by the intercept of the
logistic model. An intercept of minus infinity (or simply an
extremely large negative value) corresponds to a cure
fraction of zero. In that case all subjects are at risk. The
logistic effect parameter (i.e., the log(odds ratio)) models
the contribution of a risk allele to disease risk.
On the other hand, the survival component of the cure
model models the age of onset for subjects who will
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develop the disease. A popular survival model is the Cox
proportional hazard (PH) model. The Cox PH model
assumes that the hazard ratio is constant over time. The
hazard is a measure of how likely it is that an event will
happen at a particular time given that it has not yet hap-
pened. For example, if 0.9 % of people die exactly at age
60 and 90 % of people die at 60 or older, then the hazard of
dying at age 60 is approximately 0.9 %/90 % = 1 %.
Although the hazard of dying may change over time, the
proportional hazards assumption implies that the ratio of
hazards between risk allele carriers and non-carriers is
constant over time. The Cox PH model is elegant in that it
does not make any assumptions about the hazard function
itself, but only about the proportion of two hazard
functions.
Although the Cox PH model is useful for analyzing
survival data, it cannot be used to simulate data as it is a
semi-parametric model and does not specify the hazard
function. Therefore we have chosen the parametric Weibull
accelerated failure time (AFT) model to model age of onset
in our cure model, since it meets the proportional hazard
assumption of the Cox PH model (Kleinbaum and Klein
1996). Moreover, the AFT parameter of the Weibull AFT
model and the hazard ratio of the Cox PH model provide
different interpretations on the same survival effect, since
both parameters can be converted into each other. There-
fore we can choose a hazard ratio, convert it into an AFT
parameter and use the Weibull AFT model to simulate age
at event for subjects who are at risk. The Weibull AFT
model has three parameters: the survival SNP effect size
and a scale and rate parameter of the Weibull distribution.
Depending on the interpretation, the survival SNP effect
size models the contribution of a risk allele to the hazard
[log(hazard ratio)] or the expected age of initiation
[log(AFT parameter)]. The scale and rate parameter of the
Weibull distribution determines the distribution of age of
onset for subjects carrying no risk allele at that SNP. Since
we will not study the effect of the scale and rate parame-
ters, we arbitrarily fixed both parameters at twenty. This
corresponds to a median age of onset of 19.6 years and a
variance of 1.56 years.
For the SNP of interest (i.e., the SNP to be analyzed
while ignoring all other background SNPs) we modeled
two allelic effect size parameters: an odds ratio (OR) for
the logistic allelic effect and a hazard ratio (HR) for the
survival allelic effect. In addition to these SNP parameters,
we also simulated a logistic and survival effect for genetic
background risk. The genetic background risk is the
cumulative genetic risk of all other SNPs that are not
currently analyzed. Although we include the background
risk as a covariate in our simulation model, we will omit
the covariate in the analysis models to approximate a tra-
ditional GWA analysis, in which each SNP is analyzed
independently, while ignoring other SNPs. In the simula-
tion model, the genetic background risk is normally dis-
tributed with mean zero. In other words, an individual with
a genetic background risk of zero represents an average
amount of genetic background risk. In our simulations, we
set the background heritability to 0 % (no background risk)
or 50 % (background risk) respectively, for both logistic






 þ Var eð Þ
where Var is variance, e is the error defined on a linear
scale (log(OR) or log(age of onset) respectively), bbg is the
background effect size, and Xbg is a random variable rep-
resenting the genetic background risk.
To facilitate comparison of SNP effect sizes, we define
the SNP heritability as:
h2SNP ¼
b2SNPVar XSNPð Þ
b2SNPVar XSNPð Þ þ b2bgVar Xbg
 þ Var eð Þ
where SNP is the SNP to be analyzed, bSNP its effect size
on a linear scale [log(OR) or log(age at event) respec-
tively], and XSNP a random variable representing the
number of risk alleles present. In the model we set
Var(Xbg) = 37,500 and Var(XSNP) = 0.375, correspond-
ing to allele frequencies of 0.25 and 100,000 background
SNPs. Finally, we set Var(e) to the standard variance of the
error distribution corresponding to the type of effect (i.e.,
logistic or survival). Fixing these parameters for all simu-
lation models results in a one to one correspondence
between effect size (i.e., OR and HR) and heritability.
Survival data typically involves censoring: the unavail-
ability of age of onset for some subjects. For example,
subjects who have not been affected by disease at the time
of their assessment have an unknown age of disease onset
and are therefore referred to as censored. An important
assumption in survival analysis is uninformed censoring.
This means that whether or not a subject is censored is
unrelated to age of onset. In other words, censored subjects
should on average develop the disease at the same time as
uncensored subjects. We assumed uninformed censoring in
our simulation model. To simulate censoring we assumed
uniform right-censoring between the ages of 15 and
25 years. This interval covers the range of plausible values
for age of onset in our simulation model. In other words,
each subject drops out of the study randomly at an age
between 15 and 25 years old. If, by that time, the subject
has not contracted the disease of interest, he or she is
censored and age of onset is unknown.
The above model results in the simulation of essential
characteristics of survival GWA data with logistic and/or
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survival SNP effects, at varying cure fractions, and at a
particular genetic background risk.
Analysis model comparison
To investigate the implications of analyzing data using
traditional survival or logistic analysis, while the data is in
fact generated according to a cure model, we have simu-
lated 10,000 data sets of 500 subjects for 152 parameter
combinations. We varied the following parameters: (1)
logistic SNP heritability [0, 1 %], (2) survival effect SNP
heritability [0, 1 %], (3) background heritability for logistic
and survival effects [0, 50 %], and (4) cure fraction
0–90 % with steps of 5 %. For each simulated data set, we
have estimated the odds ratio using a logistic regression
model and the hazard ratio using a semi-parametric Cox
PH model. We will report type-1 error rate, power, and bias
of effect sizes.
To investigate the value of using a cure analysis model
to estimate the logistic and survival effect simultaneously,
we have also analyzed a subset of the simulated data with a
cure Cox PH model instead of the traditional Cox PH
model. In the cure analysis a semi-parametric PH mixture
cure model was fitted using the expectation–maximization
(EM) algorithm (Dempster et al. 1977). Since the lifetime
disease status of currently healthy subjects is unknown, this
status can be considered a latent variable. In the EM
algorithm parameters are first initialized arbitrarily and
then refined iteratively in a two-step approach. First the
expected cure status (the latent variable) of all subjects is
computed based on the current model parameter estimates
(E-step). This expected cure status is subsequently used to
readjust the cure model parameters by maximizing the
(partial) log likelihood of the traditional Cox survival
model (M-step). Although this procedure is guaranteed to
converge to a local optimum, convergence of the EM
algorithm in mixture models can be relatively slow. For
further details about the estimation method used we refer to
Cai et al. (2012).
Since fitting the cure Cox PH model was computation-
ally demanding, we restricted the analysis to the following
20 parameter combinations: (1) logistic and survival SNP
heritability both 0 % or 1 %, (2) background heritability
0 % or 50 %, and (3) cure fraction [10, 30, 50, 70, 90 %].
In addition to type-1 error, power, and bias, we will also
report the running time for the cure PH analysis, since this
type of analysis is expected to be computationally more
demanding.
All results are reported as median values based on
10,000 simulations. We used a significance threshold of 0.1
instead of the traditional threshold of 0.05 to increase the
reliability of the type-1 error rate estimates. This choice
does not affect our qualitative conclusions. All statistical
analyses were performed in R version 3.1.0 using the glm,
survival, and smcure packages respectively (R Core Team
2012). Data simulation was performed in R as well.
Results
Traditional analysis of cure data
Type 1 error
The type-1 error rate of both logistic regression and Cox
PH analysis is controlled at the specified alpha level. Fig-
ure 1 shows the type-1 error rate (alpha = 0.1) as a func-
tion of cure fraction. Figure 1a shows results based on a
simulation model without genetic background risk (0 %),
while Fig. 1b is based on a model with 50 % background
heritability for both the logistic and survival effect. The
results indicate that neither the introduction of cure frac-
tions nor genetic background risk inflate the type-1 error
rate of logistic and Cox PH analysis.
Power
The power to detect either type of genetic effect with tra-
ditional logistic and survival analysis depends on the types
of genetic effect that are present in the simulated cure data.
We distinguish three types of genetic variants: (1) variants
with only a logistic effect, (2) variants with only a survival
effect, and (3) variants with both a logistic and a survival
effect. Figure 2 shows the power of logistic regression and
Cox PH analysis as a function of cure fraction for each of
these three combinations of genetic effects. As mentioned
before, a cure fraction of 0 corresponds to a traditional
survival model where no logistic effect is defined, while a
cure fraction of 1 corresponds to a situation in which none
of the subjects will ever contract the disease and neither a
logistic effect nor a survival effect can be defined. We
therefore focus mostly on cure fractions between 0 and 1.
The first type of variant only exhibits a logistic effect
(Fig. 2a, b). If no genetic background risk is present, power
initially increases with cure fraction, but decreases again as
the cure fraction approaches 1 (Fig. 2a). This is true for both
the logistic and the Cox PH analysis. Because the logistic
effect is not defined at a cure fraction of 0, the power to detect
a logistic effect starts at type-1 error rate. Note that the Cox
PH analysis is sensitive to logistic effects, since no survival
effect is actually present. In fact, the power of Cox PH
analysis to detect logistic effects is higher than that of the
logistic analysis, which can be explained by the fact that the
latter does not account for uninformed censoring.
The results in the previous paragraph are based on a
simulation model without genetic background risk. When
272 Behav Genet (2016) 46:269–280
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we introduce genetic background heritability (50 %) in the
model, the power profile changes in a similar way for the
Cox PH and logistic analysis (Fig. 2b). First of all, the
difference in power between the two analyses decreases.
Furthermore, the introduction of genetic background risk
decreases the power for both analyses for most cure frac-
tions (\0.8).
The second model only exhibits a survival effect
(Fig. 2c, d). If no genetic background risk is present
(Fig. 2a), the power of the Cox PH analysis is optimal if
the cure fraction is zero. Its power decreases and approa-
ches the type-1 error rate as the cure fraction approaches
one, because less and less subjects will ever experience the
event. This is why data with a cure fraction close to one
(i.e., very few subject ever experience the event) cannot be
analyzed. Compared to Cox PH analysis, logistic analysis
has much lower power, because no logistic effect is pre-
sent. However, logistic analysis is somewhat sensitive to
the survival effect, since the power is larger than the type-1
error rate at low cure fractions (\0.5).
The power curves of logistic and survival analysis are
qualitatively similar for models with background heri-
tability (50 %) (Fig. 2d). However, compared to models
without genetic background risk, the power of survival
analysis is lower, while that of logistic regression is higher.
The third type of model exhibits both a survival effect
and a logistic effect of equal size (h2 = 1 %) (Fig. 2e, f).
The power to detect either type of genetic effect is there-
fore a function of the power to detect logistic only effects
and survival only effects The results indicate that in a
model with no genetic background risk the power of Cox
PH analysis remains high for cure fractions\0.5 (Fig. 2e).
This can be explained by the fact that at low cure fractions
(\0.25) the analysis is sensitive to logistic effects, while at
higher ([0.25) cure fractions Cox PH analysis is sensitive
to survival effects. On the other hand, the power of logistic
analysis to detect either type of genetic effect is very
similar to the power to detect a logistic only effect, since
logistic analysis has low power to detect survival effect.
Again, the power curves for both types of analysis are
qualitatively similar if we introduce background heritabil-
ity (50 %) (Fig. 2d). Compared to models without genetic
background risk, the power of survival analysis is lower in
models with genetic heritability, while the power of
logistic regression is higher.
Bias
We also investigated the bias in parameter estimates when
performing logistic regression and Cox PH analysis with
cure model data. First we compare the odds ratio estimate
of the logistic analysis for data including only a logistic
effect with the estimate for data with both a logistic and a
survival effect. Figure 3a shows the median estimated odds
ratio of 10,000 simulations as a function of cure fraction if
no genetic background risk is present. We consider two
situations: analyzing simulated data including only a
logistic effect and analyzing simulated data including both
a logistic and a survival effect. The estimated odds ratio in
both situations slightly increases with cure fraction at first
(cure fractions\0.5), before it decreases again as the cure
fraction approaches 1 (cure fractions[0.5). However, in
Fig. 1 Type-1 error rate (alpha = 0.1) as function of cure fraction for
logistic and Cox PH analysis coefficients. a Simulation data without
background heritability. b Simulation data with 50 % background
heritability for both logistic and survival effects. The SNP heritability
of logistic and survival effect is 0 %
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Fig. 2 Power as function of cure fraction for logistic and Cox PH
analysis. a, b Logistic SNP heritability 1 %. c, d Survival SNP
heritability 1 %. e, f Logistic and survival SNP heritability 1 %. Left
simulation data without background heritability. Right simulation data
with 50 % background heritability for both logistic and survival
effect. Horizontal line represents type-1 error rate (0.1)
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both situations the odds ratio is greatly underestimated.
Again this is due to the fact that a logistic analysis does not
account for uninformed censoring. Since all censored cases
are considered controls in the logistic analysis, the logistic
effect is underestimated. This underestimation is somewhat
less if the analyzed genetic variant exhibits both a logistic
and a survival effect.
A similar picture emerges if we introduce background
heritability (50 %) into the model (Fig. 3b). The main
difference is that the odds ratio used to simulate the data is
larger. This is because in both models the explained vari-
ance of the logistic effect is set to 1 %. Therefore,
increasing the background heritability results in an increase
of the simulated odds ratio.
Next we compare the median hazard ratio estimates of
the Cox PH analysis for simulated data including only a
survival effect with estimates for simulated data including
a survival effect and a logistic effect. The results in the
absence of background heritability are shown in Fig. 3c. If
only survival effects are present, the median estimated
hazard ratio decreases with cure fraction. If the cure frac-
tion is 0, the assumptions of the Cox PH analysis are met
and the estimate of the hazard ratio is unbiased. However,
as the cure fraction increases the assumption of uninformed
censoring no longer holds, since clearly unaffected subjects
will be more likely to be never affected by disease than
affected subjects, resulting in increased bias. On the other
hand, if both logistic and survival effects are present, the
estimated hazard ratio increases with cure fraction. The
sensitivity to detect the logistic effect not only offsets the
underestimation, but even results in overestimation if the
cure fraction is larger than 0.
The same qualitative pattern is observed for data with
genetic background risk (Fig. 3d). However, due to an
Fig. 3 Median effect size estimate of 10,000 simulations as a
function of cure fraction for logistic (a, b) and Cox PH analysis (a, b).
Left plots simulation data without background heritability. Right plots
simulation data with 50 % background heritability for both logistic
and survival effect. The horizontal line represents the simulated effect
size
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overall decrease of the estimated hazard ratio and an
increase of the simulated hazard ratio, all analyses result in
underestimation.
Cure analysis of cure data
The bias in traditional analyses of cure survival data is
caused by model misspecification. Alternatively, we could
apply a cure survival analysis. Contrary to the traditional
logistic and Cox PH analysis, the cure PH analysis simul-
taneously estimates both the odds ratio and the hazard
ratio. In the following section we report the type-1 error,
power, and bias in parameter estimation of a cure survival
analysis compared to the traditional analyses.
Type 1 error
As in the traditional analyses, the type-1 error rate for the
estimated odds ratio and hazard ratio of the cure PH model
is controlled at the specified significance threshold (al-
pha = 0.1) for all cure fraction in models without back-
ground heritability (Fig. 4a). In fact the type-1 error rate
for the estimated cure HR seems somewhat lower than that
of the traditional estimates at cure fractions near 0 and 1.
The type-1 error rate is closer to alpha for models in which
background heritability is present for both the logistic and
the survival effect (h2 = 50 %) (Fig. 4b).
Power
Figure 5a shows the power for all four estimates (i.e., Cox
PH hazard ratio, cure hazard ratio, logistic odds ratio, and
cure odds ratio) as a function of cure fraction in a model
with both logistic and survival effects. The power curves
for the cure model have a shape similar to the power curves
of their respective traditional analyses. However, the power
of the cure analysis is lower. The traditional analyses are
sensitive to both types of effects, which results in increased
power to detect either type of effect. In contrast, the two
estimates of the cure PH model are only sensitive to the
odds ratio or hazard ratio respectively. In other words, the
power curves of the cure PH analysis provide a more
accurate picture of the power to detect the type of effect
corresponding to the type of effect size (i.e., OR or HR).
While there is no model misspecification for models
with no background heritability, misspecification is a
problem for models with genetic background heritability.
Figure 5b shows that the power to detect a survival effect
decreases considerably in models with 50 % background
heritability compared to models without genetic back-
ground risk. This drop in power is larger for the cure PH
analysis than for the traditional Cox PH analysis. On the
other hand, the power to detect a logistic effect with a cure
PH analysis increases if genetic heritability is introduced
compared to a model without genetic background risk.
Bias
Finally, we compare the bias of traditional estimates and
the cure PH estimates of the odds ratio and hazard ratio
respectively. Figure 6a shows that the estimated odds ratio
of the cure PH analysis is unbiased for a large range of cure
fractions, while the estimate of the logistic analysis is
severely underestimated as we have seen before. However,
when we introduce genetic background risk the odds ratio
of the cure PH analysis is underestimated as well, although
not as much as the estimate of the logistic regression
(Fig. 6b).
Fig. 4 Type-1 error rate (alpha = 0.1) as a function of cure fraction
for the cure model OR and HR coefficients compared to traditional
logistic and Cox PH analysis coefficients. The SNP heritability of
logistic and survival effect is 0 %. a Simulation data without
background heritability. b Simulation data with 50 % background
heritability for both logistic and survival effects
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The estimate of the hazard ratio of the cure PH analysis
is also relatively unbiased across cure fractions compared
to the estimate of the Cox PH analysis if no genetic
background risk is assumed. (Figure 6c). However, in the
model with 50 % background heritability, both Cox PH
analysis and cure PH analysis results in underestimated
hazard ratio for varying cure fractions.
Analysis runtime
The fitting procedure for the cure PH model is computa-
tionally intensive. The median time over 10,000 simula-
tions for fitting a cure PH model increased from 26 to 40 s
as the cure fraction varied from 0.9 to 0.1 (data not shown).
As the cure fraction approaches 0, convergence of the fit-
ting procedure gets more difficult, since the odds ratio is
not identified if the cure fraction is zero.
Discussion
In this simulation study, we have compared different
analysis methods to identify genetic effects in genome-
wide survival data. Our first aim was to investigate the
influence of a cure fraction on parameter estimation in
traditional logistic analysis and survival analysis. Although
logistic regression is typically used to detect genetic vari-
ants that affect disease risk, and Cox PH regression is used
to detect variants that affect time to disease onset, our
simulation results show that, in the presence of a cure
fraction, both types of analysis can be sensitive to either
type of effect. When performing a genome-wide Cox PH
analysis to identify genetic variants that affect time to
disease onset, the estimated hazard ratios may be inflated if
the genetic variants also affect disease risk. In fact, if
genetic variants only influences disease risk, but not age of
onset, a traditional survival analysis may erroneously
conclude that an age of onset effect is present. Moreover,
performing a logistic analysis to estimate the genetic effect
on disease risk is even more problematic, since logistic
analysis does not take into account the censoring typically
observed in survival data. Our results indicate that in this
context the power of logistic analysis to detect a logistic
effect is even lower than that of Cox PH analysis. In
summary, when a cure fraction is present both logistic
regression and Cox PH regression result in biased estimates
of genetic effect sizes. Note that due to model misspecifi-
cation it is to be expected that logistic analysis or Cox
survival analysis are suboptimal when applied to cure
model data. However, our results show that under a cure
model the traditional Cox survival model is not just biased,
but that it can identify age of onset effects that do not exist.
Whether or not a cure model is applicable depends on the
genetic architecture of the data at hand. Some genetic
variants may influence either disease risk or age of onset,
while others may influence both.
Our second aim was to investigate whether the cure
model offers advantages over traditional survival analysis.
We have applied a relatively unknown model that allows
for the estimation of both logistic and survival effects: the
cure survival model. Under a cure model, cure survival
analysis leads to unbiased estimates, but only in the
Fig. 5 Power as function of cure fraction for cure model OR and HR
coefficients compared to traditional logistic and Cox PH analysis.
Logistic and survival SNP heritability 1 %. a Simulation data without
background heritability. b Simulation data with 50 % background
heritability for both logistic and survival effect. Horizontal line
represents alpha level (0.1)
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absence of background genetic risk. It is not surprising
that survival data simulated with a cure survival model is
best analyzed with a cure survival analysis, as our results
imply. So why not always use a cure survival analysis if
we suspect a cure fraction? Unfortunately, the cure sur-
vival mixture model is computationally too demanding to
apply at a genome-wide scale. A running time of 25 s per
SNP for analyzing 5 million SNPs would amount to 1446
computing days on a single core for only 500 subjects.
This is prohibitively long for most GWA studies. Fur-
thermore, the logistic effect of the cure model is
unidentified if the cure fraction is zero or one and there-
fore if the cure fraction is close to either boundary the
running time increases further or even worse, the algo-
rithm does not converge. On the other hand, the above
running times do allow a post hoc analysis of a limited
number of potentially interesting findings. Similarly, cure
survival analysis can be used in candidate gene or repli-
cation analyses, in which a relatively small number of
genetic variants are typically tested.
Although cure survival analysis removes bias in
parameter estimation due to cure fractions, it does not
remove bias due to genetic background risk. This latter bias
also occurs in traditional case–control GWA studies (Gail
et al. 1984; Stringer et al. 2011). Since large amounts of
background heritability is typical in complex diseases
(Gratten et al. 2014), cure analysis will result in biased
estimates of both the logistic and the survival effect. Our
results suggest that a cure survival analysis will underes-
timate both effects and that this underestimation is rela-
tively independent from the cure fraction. Although the
odds ratio of a cure survival analysis is less biased than that
of a traditional logistic regression, its hazard ratio is more
biased than that of a Cox PH regression.
Fig. 6 Median effect size estimate of 10,000 simulation of cure
survival model and traditional model as a function of cure fraction for
odds ratio (OR) (a, b) and hazard ratio (HR) (a, b). Left panels
simulation data without background heritability. Right panels simu-
lation data with 50 % background heritability for both logistic and
survival effect. Horizontal line represents the simulated effect size
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In many genome-wide survival studies of mental or
physical disorders, we do not expect that all subjects will
eventually develop the disease of interest. Based on our
results, we therefore provide three recommendations for
genetic analysis of diseases or other phenotypes that will
not affect the entire population.
Our first recommendation is to follow-up significant
hits resulting from a Cox PH analysis with a cure PH
analysis. Cure survival analysis allows separation of
genetic variants which primarily influence the time of
disease onset from those variants that primarily influ-
ence disease risk. Distinguishing these two types of
genetic variants may provide valuable insight into the
biological processes behind a disease. However, as our
results suggest, cure survival analysis should be only
considered if the cure fraction in the sample is suffi-
ciently large (e.g. [0.1), but not too large (e.g. \0.9).
This means for a population cohort that the disease of
interest should have a lifetime prevalence between 10
and 90 %. Since most disease prevalences are \10 %,
sampling from a high-risk population could be consid-
ered to decrease the cure fraction in the sample.
Although in principle cure analysis is likely to improve
prediction of both disease risk and age of onset in
independent samples under a cure model, in practice
outcome prediction using a small number of genetic
variants is difficult in complex traits that are influenced
by many variants across the genome.
We also recommend that if distinguishing the type of
genetic effect (logistic vs survival) is not a primary con-
cern, a genome-wide Cox PH analysis should be used to
maximize the power to detect either type of genetic effect.
Our results show that the power of a Cox PH analysis to
detect either type of genetic effect is larger than that of the
cure survival analysis.
Our third recommendation is that power analyses of
genome-wide survival studies should account for cure
fraction, logistic and survival effect sizes, and background
heritability. Ignoring these factors will greatly influence the
estimated power. A reasonable assumption for the cure
fraction is 1 – lifetime prevalence. Effect sizes are difficult
to predict in advance and ideally power is calculated for a
range of potential effect sizes for both the logistic and the
survival effect. Finally, for complex diseases it is safe to
assume that the background heritability will be close to the
disease heritability. Although general power calculators for
survival analysis exist, such as the genetic power calculator
for case–control and quantitative trait GWA studies (Pur-
cell et al. 2003), we are not aware of programs or web tools
that are tailored towards genome-wide survival studies.
However, power analysis through a simplified simulation
of GWA data is a viable alternative as exemplified by this
simulation study.
The results of this simulation study should be interpreted
in the context of two limitations. First, it was not compu-
tationally feasible to vary all relevant model parameters.
For example, we used a small sample of 500 subjects in all
our simulations and investigated only a limited number of
combinations of effect sizes. Second, data were simulated
according to a single distribution: the Weibull distribution.
In reality, survival data may be distributed differently. The
implications and recommendations of this study are
therefore more qualitative than quantitative in nature.
The primary focus of this study was to investigate the
impact of cure fractions and genetic background risk on bias
in genome-wide survival analysis. However, other factors
may introduce bias in a genome-wide survival analysis. For
example, the assumption of uninformed censoring may not
hold, resulting in underestimated or overestimated hazard
ratios depending on the type of informed censoring. Simi-
larly, a GWA sample may include multiple family members
of a family. In that case sandwich estimation can be used to
account for the correlations caused by family relations within
a sample (Borecki and Province 2008; Diggle et al. 2002).
This type of estimation increases the standard error of the
estimate to correct for dependence due to familial related-
ness. Studying the effects of different types of censoring and
presence of familial relatedness on bias and power was
beyond the scope of this study, but these effects warrant
further research.
In conclusion, cure fractions introduce the possibility of
investigating the impact of both logistic and survival
effects of a single genetic variant. Cure survival analysis
takes this complexity into account. Although the applica-
tion of cure survival analysis is not feasible at a genome-
wide scale, we have shown that follow-up of a specific
subset of SNPs may provide information about logistic and
survival effects in a relatively unbiased way. Distinguish-
ing genetic variants affecting disease onset and those
affecting disease risk is an important step in understanding
the nature of genetic effects in (neuro)psychiatric disorders.
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